Skip to main content
Cancer Questions?

Sarah Cannon Leadership and Physician Experts

Photo of Gerald S. Falchook, MD, MS

Gerald S. Falchook, MD, MS

Director, Drug Development

Dr. Falchook is the medical director of Sarah Cannon Research Institute at HealthONE, a clinical trials program which opened in 2014 in Denver for patients with advanced cancer. Previously, Dr. Falchook was a faculty member at U.T. MD Anderson Cancer Center for six years, developing investigator-initiated clinical trials, as well as collaborating with biotech industry partners to bring promising new drugs to cancer patients.

Dr. Falchook has been the principal investigator or co-investigator of more than 200 clinical studies, including first-in-human studies and regimens that have received FDA approval. His research has been published extensively in peer-reviewed journals, including in the New England Journal of Medicine and The Lancet.